United States Antibody Fragments Market Report 2017

December 2017 | 97 pages | ID: U8FA8E339DFEN
QYResearch

Abstracts

In this report, the United States Antibody Fragments market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antibody Fragments in these regions, from 2012 to 2022 (forecast).

United States Antibody Fragments market competition by top manufacturers/players, with Antibody Fragments sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• F. Hoffmann-La Roche
• Johnson & Johnson
• Amgen
• Bristol-Myers Squibb
• AbbVie
• Takeda Pharmaceutical
• Sanofi
• Biogen
• Eli Lilly

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• F(ab) Fragment
• F(ab’)2 Fragment

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Cancer
• Immunodeficiencies
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antibody Fragments Market Report 2017

1 ANTIBODY FRAGMENTS OVERVIEW

1.1 Product Overview and Scope of Antibody Fragments
1.2 Classification of Antibody Fragments by Product Category
  1.2.1 United States Antibody Fragments Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Antibody Fragments Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 F(ab) Fragment
  1.2.4 F(ab’)2 Fragment
1.3 United States Antibody Fragments Market by Application/End Users
  1.3.1 United States Antibody Fragments Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cancer
  1.3.3 Immunodeficiencies
  1.3.4 Other
1.4 United States Antibody Fragments Market by Region
  1.4.1 United States Antibody Fragments Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Antibody Fragments Status and Prospect (2012-2022)
  1.4.3 Southwest Antibody Fragments Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Antibody Fragments Status and Prospect (2012-2022)
  1.4.5 New England Antibody Fragments Status and Prospect (2012-2022)
  1.4.6 The South Antibody Fragments Status and Prospect (2012-2022)
  1.4.7 The Midwest Antibody Fragments Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antibody Fragments (2012-2022)
  1.5.1 United States Antibody Fragments Sales and Growth Rate (2012-2022)
  1.5.2 United States Antibody Fragments Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTIBODY FRAGMENTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antibody Fragments Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antibody Fragments Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antibody Fragments Average Price by Players/Suppliers (2012-2017)
2.4 United States Antibody Fragments Market Competitive Situation and Trends
  2.4.1 United States Antibody Fragments Market Concentration Rate
  2.4.2 United States Antibody Fragments Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antibody Fragments Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIBODY FRAGMENTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Antibody Fragments Sales and Market Share by Region (2012-2017)
3.2 United States Antibody Fragments Revenue and Market Share by Region (2012-2017)
3.3 United States Antibody Fragments Price by Region (2012-2017)

4 UNITED STATES ANTIBODY FRAGMENTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Antibody Fragments Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antibody Fragments Revenue and Market Share by Type (2012-2017)
4.3 United States Antibody Fragments Price by Type (2012-2017)
4.4 United States Antibody Fragments Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTIBODY FRAGMENTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antibody Fragments Sales and Market Share by Application (2012-2017)
5.2 United States Antibody Fragments Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIBODY FRAGMENTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antibody Fragments Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche
  6.2.2 Antibody Fragments Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 F. Hoffmann-La Roche Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
  6.3.2 Antibody Fragments Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson & Johnson Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Amgen
  6.4.2 Antibody Fragments Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
  6.5.2 Antibody Fragments Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bristol-Myers Squibb Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AbbVie
  6.6.2 Antibody Fragments Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AbbVie Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Takeda Pharmaceutical
  6.7.2 Antibody Fragments Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Takeda Pharmaceutical Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sanofi
  6.8.2 Antibody Fragments Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sanofi Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biogen
  6.9.2 Antibody Fragments Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biogen Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Eli Lilly
  6.10.2 Antibody Fragments Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Eli Lilly Antibody Fragments Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ANTIBODY FRAGMENTS MANUFACTURING COST ANALYSIS

7.1 Antibody Fragments Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antibody Fragments

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antibody Fragments Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antibody Fragments Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Antibody Fragments Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antibody Fragments Sales Volume Forecast by Type (2017-2022)
11.3 United States Antibody Fragments Sales Volume Forecast by Application (2017-2022)
11.4 United States Antibody Fragments Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antibody Fragments
Figure United States Antibody Fragments Market Size (K Pcs) by Type (2012-2022)
Figure United States Antibody Fragments Sales Volume Market Share by Type (Product Category) in 2016
Figure F(ab) Fragment Product Picture
Figure F(ab’)2 Fragment Product Picture
Figure United States Antibody Fragments Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Antibody Fragments by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Immunodeficiencies Examples
Table Key Downstream Customer in Immunodeficiencies
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Antibody Fragments Market Size (Million USD) by Region (2012-2022)
Figure The West Antibody Fragments Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antibody Fragments Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antibody Fragments Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antibody Fragments Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antibody Fragments Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antibody Fragments Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody Fragments Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Antibody Fragments Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody Fragments Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Antibody Fragments Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Antibody Fragments Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody Fragments Sales Share by Players/Suppliers
Figure 2017 United States Antibody Fragments Sales Share by Players/Suppliers
Figure United States Antibody Fragments Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antibody Fragments Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antibody Fragments Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody Fragments Revenue Share by Players/Suppliers
Figure 2017 United States Antibody Fragments Revenue Share by Players/Suppliers
Table United States Market Antibody Fragments Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Antibody Fragments Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Antibody Fragments Market Share of Top 3 Players/Suppliers
Figure United States Antibody Fragments Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antibody Fragments Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antibody Fragments Product Category
Table United States Antibody Fragments Sales (K Pcs) by Region (2012-2017)
Table United States Antibody Fragments Sales Share by Region (2012-2017)
Figure United States Antibody Fragments Sales Share by Region (2012-2017)
Figure United States Antibody Fragments Sales Market Share by Region in 2016
Table United States Antibody Fragments Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antibody Fragments Revenue Share by Region (2012-2017)
Figure United States Antibody Fragments Revenue Market Share by Region (2012-2017)
Figure United States Antibody Fragments Revenue Market Share by Region in 2016
Table United States Antibody Fragments Price (USD/Pcs) by Region (2012-2017)
Table United States Antibody Fragments Sales (K Pcs) by Type (2012-2017)
Table United States Antibody Fragments Sales Share by Type (2012-2017)
Figure United States Antibody Fragments Sales Share by Type (2012-2017)
Figure United States Antibody Fragments Sales Market Share by Type in 2016
Table United States Antibody Fragments Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antibody Fragments Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody Fragments by Type (2012-2017)
Figure Revenue Market Share of Antibody Fragments by Type in 2016
Table United States Antibody Fragments Price (USD/Pcs) by Types (2012-2017)
Figure United States Antibody Fragments Sales Growth Rate by Type (2012-2017)
Table United States Antibody Fragments Sales (K Pcs) by Application (2012-2017)
Table United States Antibody Fragments Sales Market Share by Application (2012-2017)
Figure United States Antibody Fragments Sales Market Share by Application (2012-2017)
Figure United States Antibody Fragments Sales Market Share by Application in 2016
Table United States Antibody Fragments Sales Growth Rate by Application (2012-2017)
Figure United States Antibody Fragments Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Antibody Fragments Sales Growth Rate (2012-2017)
Figure Novartis Antibody Fragments Sales Market Share in United States (2012-2017)
Figure Novartis Antibody Fragments Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Antibody Fragments Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Antibody Fragments Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Antibody Fragments Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Antibody Fragments Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Antibody Fragments Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Antibody Fragments Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Antibody Fragments Sales Growth Rate (2012-2017)
Figure Amgen Antibody Fragments Sales Market Share in United States (2012-2017)
Figure Amgen Antibody Fragments Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Antibody Fragments Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Antibody Fragments Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Antibody Fragments Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Antibody Fragments Sales Growth Rate (2012-2017)
Figure AbbVie Antibody Fragments Sales Market Share in United States (2012-2017)
Figure AbbVie Antibody Fragments Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Antibody Fragments Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Antibody Fragments Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceutical Antibody Fragments Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Antibody Fragments Sales Growth Rate (2012-2017)
Figure Sanofi Antibody Fragments Sales Market Share in United States (2012-2017)
Figure Sanofi Antibody Fragments Revenue Market Share in United States (2012-2017)
Table Biogen Basic Information List
Table Biogen Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Antibody Fragments Sales Growth Rate (2012-2017)
Figure Biogen Antibody Fragments Sales Market Share in United States (2012-2017)
Figure Biogen Antibody Fragments Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Antibody Fragments Sales Growth Rate (2012-2017)
Figure Eli Lilly Antibody Fragments Sales Market Share in United States (2012-2017)
Figure Eli Lilly Antibody Fragments Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Fragments
Figure Manufacturing Process Analysis of Antibody Fragments
Figure Antibody Fragments Industrial Chain Analysis
Table Raw Materials Sources of Antibody Fragments Major Players/Suppliers in 2016
Table Major Buyers of Antibody Fragments
Table Distributors/Traders List
Figure United States Antibody Fragments Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Antibody Fragments Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antibody Fragments Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Antibody Fragments Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antibody Fragments Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antibody Fragments Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Antibody Fragments Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antibody Fragments Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antibody Fragments Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Antibody Fragments Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Antibody Fragments Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody Fragments Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody Fragments Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources